Evidence map›Paper›PMID 27472881›Full record

ArticleJournal of Alzheimer's disease : JAD2016

Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.

Marzena Ułamek-Kozioł, Janusz Kocki, Anna Bogucka-Kocka, Alicja Petniak, Paulina Gil-Kulik, Sławomir Januszewski, Jacek Bogucki, Mirosław Jabłoński, Wanda Furmaga-Jabłońska, Judyta Brzozowska and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Guideline
  2. Genomic and proteomic conversion of brain ischemia to Alzheimer's disease.Frontiers in cell and developmental biology · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Alterations ofCurrent Alzheimer research · 2025
    Article
  10. Article
  11. Article
  12. International journal of molecular sciences · 2024
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Marzena Ułamek-KoziołFirst Department of Neurology, Institute of Psychiatry and Neurology, Warsaw, Poland.
Janusz KockiDepartment of Clinical Genetics, Medical University of Lublin, Lublin, Poland.
Anna Bogucka-KockaDepartment of Biology and Genetics, Medical University of Lublin, Lublin, Poland.
Alicja PetniakDepartment of Clinical Genetics, Medical University of Lublin, Lublin, Poland.
Paulina Gil-KulikDepartment of Clinical Genetics, Medical University of Lublin, Lublin, Poland.
Sławomir JanuszewskiLaboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Jacek BoguckiWarsaw Higher Humanistic School, Warsaw, Poland.
Mirosław JabłońskiDepartment of Rehabilitation and Orthopaedics, Medical University of Lublin, Lublin, Poland.
Wanda Furmaga-JabłońskaDepartment of Neonate and Infant Pathology, Medical University of Lublin, Lublin, Poland.
Judyta BrzozowskaDepartment of Clinical Psychology, Medical University of Lublin, Lublin, Poland.
Stanisław J CzuczwarDepartment of Pathophysiology, Medical University of Lublin, Lublin, Poland.
Ryszard PlutaLaboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Medical University of Lublin · PLMossakowski Medical Research Institute, Polish Academy of Sciences · PLInstitute of Psychiatry and Neurology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic brain damage is a pathological incident that is often linked with medial temporal lobe cortex injury and finally its atrophy. Post-ischemic brain injury associates with poor prognosis since neurons of selectively vulnerable ischemic brain areas are disappearing by apoptotic program of neuronal death. Autophagy has been considered, after brain ischemia, as a guardian against neurodegeneration. Consequently, we have examined changes in autophagy (BECN 1), mitophagy (BNIP 3), and apoptotic (caspase 3) genes in the medial temporal lobe cortex with the use of quantitative reverse-transcriptase PCR following transient 10-min global brain ischemia in rats with survival 2, 7, and 30 days. The intense significant overexpression of BECN 1 gene was noted on the 2nd day, while on days 7-30 the expression of this gene was still upregulated. BNIP 3 gene was downregulated on the 2nd day, but on days 7-30 post-ischemia, there was a significant reverse tendency. Caspase 3 gene, associated with apoptotic neuronal death, was induced in the same way as BNIP 3 gene after brain ischemia. Thus, the demonstrated changes indicate that the considerable dysregulation of expression of BECN 1, BNIP 3, and caspase 3 genes may be connected with a response of neuronal cells in medial temporal lobe cortex to transient complete brain ischemia.

Indexed as

Alzheimer DiseaseAnimalsApoptosisAutophagyBeclin-1Brain IschemiaCaspase 3Disease ProgressionFemaleGene ExpressionHeart ArrestMembrane ProteinsMitochondrial ProteinsMitophagyRats, WistarReal-Time Polymerase Chain ReactionBeclin-1Becn1 protein, ratBNIP3 protein, ratCasp3 protein, ratCaspase 3Membrane ProteinsMitochondrial ProteinsAlzheimer’s diseaseBECN 1BNIP 3brain ischemiacaspase 3genesratselective vulnerabilitytemporal cortex

Identifiers

PMID27472881
PMCPMC5008226
OpenAlexW2495288752

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.